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One Sentence Summary: 
Here we describe the generation of ​Ae. aegypti mosquitoes that are engineered to confer reduced               
vector competence to Zika virus (ZIKV) and we discuss how such engineering approach can be               
used to combat the major health burden of ZIKV and potentially other arboviruses in the future.  
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 Abstract: 
Recent Zika virus (ZIKV) outbreaks have highlighted the necessity for development of            
novel vector control strategies to combat arboviral transmission, including genetic versions of            
the sterile insect technique, artificial infection with ​Wolbachia to reduce population size and/or             
vectoring competency, and gene drive based methods. Here, we describe the development of             
mosquitoes synthetically engineered to impede vector competence to ZIKV. We demonstrate that            
a polycistronic cluster of engineered microRNAs (miRNAs) targeting ZIKV is expressed and            
fully processed following a blood meal in ​Ae. aegypti ​, ensuring the formation of mature synthetic               
miRNAs in the midgut where ZIKV resides in the early stages of infection. Critically, we               
demonstrate that engineered ​Ae. aegypti mosquitoes harboring the anti-ZIKV transgene have           
significantly reduced viral infection, dissemination, and transmission rates of ZIKV. Taken           
together, these compelling results provide a promising path forward for development of effective             
genetic-based ZIKV control strategies, which could potentially be extended to curtail other            
arboviruses. 
 
Main 
Since being introduced into the Americas, ZIKV - a mosquito-borne flavivirus - has             
spread rapidly, causing hundreds of thousands of cases of ZIKV infection ​1​. Although most cases               
remain asymptomatic, infection during pregnancy has been associated with severe congenital           
abnormalities and pregnancy loss, presenting an unprecedented health threat with long-term           
consequences ​2​. This prompted the World Health Organization to declare ZIKV a Public Health              
Emergency of International Concern in 2016 ​1,2​. Currently, there are no clinically approved             
vaccines to prevent ZIKV and no effective treatment options for infected individuals; thus,             
vector control remains essential in curtailing the ZIKV epidemic. Like dengue virus (DENV) and              
chikungunya virus (CHIKV), ZIKV is transmitted primarily by ​Aedes mosquitoes, which are            
expanding their habitable range due to urbanization, climate change, and global trade ​3​. Current              
methods of vector control, including removal of standing water and use of insecticides, have not               
been entirely effective in the fight against the spread of ​Aedes mosquitoes ​3​. Therefore, new               
game-changing innovative vector control strategies, including those utilizing genetically         
engineered mosquitoes ​4​, are urgently needed to combat the spread of ZIKV and other              
Aedes​-vectored diseases worldwide.  
Employment of genetically modified (or otherwise altered) insects to manipulate          
disease-vectoring populations was first proposed decades ago ​5​, and due in part to enabling              
technological advances, has garnered increased interest in recent years ​4​. In fact, several             
strategies for genetic-based vector control are currently being utilized in the field. For example,              
the RIDL (Release of Insects carrying a Dominant Lethal) system ​6 - a genetic-based Sterile               
Insect Technique (SIT)-like system - has recently been shown to be effective in reducing wild               
insect populations ​7​. Open field release trials of these genetically modified mosquitoes have been              
conducted in several countries, including Cayman Islands, Malaysia, Brazil, and are currently            
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 being considered for use in India and the USA ​8–10​. In addition to genetic-based vector control                
strategies, mosquitoes harboring artificially acquired strains of ​Wolbachia can also be used to             
either reduce total insect populations ​11 or to render insect populations less competent vectors of               
certain viruses, including ZIKV ​12​, and this technique has also been trialed in multiple countries               
to reduce impact of mosquito-borne diseases ​13–15​. However, given the accumulating evidence            
that ​Wolbachia can enhance certain flavivirus infections ​16–18 may lead do reevaluation of this              
technique. Nevertheless, while current approaches are effective, they require inundative releases           
of large numbers of insects, which can be laborious and expensive and can impede scalability               
and worldwide adoption.  
Another category of genetic-based vector control involves an engineered gene drive           
system that can force inheritance in a super-Mendelian fashion, enabling it to increase itself - and                
any linked “cargo” genes - in frequency with each generation even without conferring fitness              
advantages to its host ​4,19​. Such a method could be used to disseminate desirable “cargo” genes,                
such as pathogen resistance, rapidly through wild disease-transmitting populations replacing          
vector populations with disease-refractory ones ​20​. While significant efforts are currently           
underway to develop engineered drive systems ​21–24​, others are focused on creation of “cargo”              
genes that may be spread by the drive systems, and several studies have reported on the                
successful development of pathogen resistance “cargo” genes in ​Ae. aegypti​ ​25–27​.  
To date, however, no anti-ZIKV refractory “cargo” genes in any mosquito have been             
developed. To fill this void, here we describe the generation of a synthetically engineered ZIKV               
resistance transgene comprising a polycistronic cluster ZIKV-targeting synthetic miRNAs. We          
demonstrate that ​Ae. aegypti mosquitoes harboring this anti-ZIKV transgene express and fully            
process the ZIKV-targeting synthetic miRNAs in the midgut and consequently have significantly            
reduced viral infection, dissemination, and transmission rates of ZIKV. Specifically, we           
demonstrate that mosquitoes homozygous for the anti-ZIKV transgene are fully resistant to            
ZIKV infection and are unable to transmit the virus. In contrast, we determine that a minority of                 
heterozygotes for the anti-ZIKV transgene can become infected with ZIKV following exposure.            
However, these heterozygotes become infected at significantly lower rates than wildtypes (WT),            
and those susceptible to infection have roughly three orders of magnitude lower viral titres in               
their saliva, suggesting a significantly reduced possibility of viral transmission. This is supported             
by our finding that heterozygous anti-ZIKV mosquitoes are almost entirely incapable of ​in vivo              
ZIKV transmission in a sensitive ​Stat1-/- mouse model. Moreover, when compared to ​Wolbachia             
w​Mel positive mosquitoes, previously shown to have reduced ZIKV vectoring competency ​12​, the             
anti-ZIKV mosquitoes perform siginficantly better in the ZIKV challenge assays. Taken           
together, these compelling results provide a promising path forward for development of effective             
ZIKV control - and possibly control of other clinically significant arboviruses - using genetically              
engineered mosquitoes. 
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 Results 
Engineering ZIKV-resistant mosquitoes 
To generate a “cargo” gene that can confer resistance to ZIKV, we implemented a              
synthetic miRNA-based approach, since such an approach has been previously demonstrated to            
generate virus-resistance phenotypes in a number of contexts (e.g., ​28–30​), including mosquitoes ​31​.             
We engineered a ​piggyBac ​vector comprising a polycistronic cluster of eight ZIKV-targeting            
synthetic miRNAs (anti-ZIKV transgene) under control of the ​Ae. aegypti carboxypeptidase           
promoter ​32 to drive expression of the synthetic miRNAs in female midguts following a blood               
meal (Figure 1A). To ensure effective viral suppression and evolutionary stability, we designed             
each of the eight synthetic miRNAs to target 6/10 conserved protein-coding genes of ​French              
Polynesia ​ZIKV strain H/PF/2013 ( ​GenBank: KJ776791.2 ​) ​33​, including all three structural genes            
(capsid (C), membrane precursor (prM), envelope (E)), and three non-structural genes (NS1,            
NS2A, NS5). Each of these genes was targeted by a single synthetic miRNA, except for the                
RNA-dependent RNA polymerase NS5, which was targeted by three miRNAs due to its             
importance for the replication of the flaviviral RNA genome (Figure 1B, Supplementary Figure             
1). The engineered anti-ZIKV transgene (termed plasmid OA959C) also contained the           
eye-specific 3xP3 promoter ​34 driving expression of tdTomato as a transgenesis marker (Figure             
1A).  
Following embryonic microinjection, multiple transgenic lines were identified (n > 6),           
and four independent lines with strong expression of tdTomato fluorescence in the eyes (termed              
TZIKV-A, B, C, and D) were selected for further characterization (see Figure 1C, 1D for               
fluorescence in TZIKV-C). ​To verify the transgene insertion sites, we performed inverse PCR             
(iPCR) on genomic DNA extracted from transgenic mosquitoes of all four independent strains.             
iPCR analysis indicated that ​insertion sites were on chromosome 2 (at approximate position             
167,899,561) ​for line TZIKV-A, on chromosome 3 (at approximate position 402,525,313) for            
line TZIKV-B, on chromosome 3 (at approximate position 173,647,983) for line TZIKV-C, and             
on chromosome 1 (at approximate position 228,972,549) for line TZIKV-D when aligned to the              
AaegL5 assembly (GenBank assembly accession: GCA_002204515.1) ​35 . To avoid any bias due             
to position effect variegation (PEV) stemming from transgene insertion sites, all four lines were              
screened for midgut infection status at day 4 post-infection (dpi), and results showed that all 4                
lines had significant reduction in midgut infection rate and viral titres compared with WT              
mosquitoes (Supplementary Figure 2). Given that there was no significant difference in ZIKV             
reduction in midgut infection between the four lines (TZIKV-A, B, C, and D), the line exhibiting                
the strongest antiviral phenotype (TZIKV-C) was selected for further comprehensive          
characterization (Supplementary Figure 2). 
 
Molecular analysis of ​synthetic miRNA expression and processing  
To confirm expression and processing of the ZIKV-targeting synthetic miRNAs in           
TZIKV-C ​, we deep-sequenced small RNA populations from dissected midgut tissues isolated           
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 from blood-fed and non-blood-fed female mosquitoes using an Illumina platform. We detected            
robust expression of the passenger ​36 and mature miRNA guide strands of 5 out of 8                
anti-ZIKV-targeting synthetic miRNAs (miRNAs 1,2,4,6,8) with TPM (transcripts per million)          
values ranging from 2 to 91, 25.7 on average, indicating that these synthetic miRNAs are               
efficiently expressed and processed (Supplementary Figure 3, Supplementary Table 1).          
Importantly, no anti-ZIKV-targeting miRNAs (>1 read) were identified in small RNA           
populations derived from WT ​Ae. aegypti (Supplementary Table 1). Taken together, these results             
demonstrate that the anti-ZIKV transgene is stably integrated into the mosquito genome and             
most of the ZIKV-targeting synthetic miRNAs are properly expressed and processed in an             
appropriate context (i.e., in midgut) for ZIKV suppression.  
 
Engineered mosquitoes are refractory to multiple ZIKV strains  
To characterize the functional significance of ​ZIKV-targeting synthetic miRNA         
expression and processing on vector competence, adult female mosquitoes (WT control and            
TZIKV-C) were infected with ZIKV (FSS13025 ​, ​Cambodia 2010 strain, GenBank JN860885)           
via membrane blood-feeding ​37​. For these experiments we used the Cambodia ZIKV strain,             
which is from the Asian ZIKV lineage and in close phylogenetic proximity to the ​French               
Polynesia ​ZIKV strain, against which the miRNAs were designed ​38​. Importantly, seven out of              
eight of the ​ZIKV-targeting synthetic miRNA target sites are 100% conserved between the             
Cambodia ZIKV strain and the ​French Polynesia strain​, allowing either strain to be used for the                
ZIKV challenges (Supplementary Figure 1). At 4 days post-infection (dpi), midguts from            
blood-fed mosquitoes were dissected and ZIKV titres were measured using real-time RT-qPCR.            
Results from 3 biological replicates revealed that none of the TZIKV-C mosquitoes homozygous             
for the transgene (n=32) were positive for ZIKV infection in the midguts. ZIKV infection was               
detected in 87.5% (28/32) of the TZIKV-C mosquitoes that were heterozygous for the transgene;              
however, these mosquitoes had significantly (p<0.001) lower viral RNA levels (~2 logs) than             
WT (Figure 2A, Table 1).  
To assay for viral dissemination, total RNA was collected from whole TZIKV-C            
mosquito carcasses and dissected midguts from both homozygous and heterozygous transgenic           
mosquitoes at 14 dpi. The results from three biological replicates indicated that none of the               
homozygous TZIKV-C mosquitoes (n=46) were positive for viral replication (dissemination) in           
either the midgut or the carcass. ZIKV prevalence was detected in 74.4% (29/39) of              
heterozygous TZIKV-C mosquitoes in both the carcass and midgut; however, they had            
significantly (p<0.001) lower levels of viral RNA (~3 logs) compared to WT (Figure 2B-C,              
Table 1). Finally, to determine viral transmission, saliva from individual mosquitoes was            
collected at 14 dpi and ZIKV titres were measured using TCID ​50 assay. No ZIKV was detected                
in the saliva of homozygous TZIKV-C mosquitoes (n=46). Prevalence of ZIKV in the saliva              
was detected in 74.4% (29/39) of heterozygous TZIKV-C mosquitoes; however, here again the             
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 ZIKV titres were significantly (p<0.001) lower (~3 logs) as compared to WT (Figure 2D, Table               
1). 
To determine whether the synthetic miRNAs are broadly inhibitory for ZIKV, vector            
competence of transgenic TZIKV-C mosquitoes was also assessed using a second contemporary            
ZIKV strain (PRVABC59, isolated from US traveller to Puerto Rico in 2015, GenBank             
KU501215). For this strain, seven out of eight ZIKV-targeting synthetic miRNA target sites             
(although not the same seven as for the Cambodia strain) are 100% conserved with the French                
Polynesia strain against which the miRNAs were designed (Supplementary Figure 1). Tests for             
infection, dissemination, and transmission were carried out as above, and the results were             
comparable to those obtained with the Cambodia strain. Briefly, at 4 dpi, none of the TZIKV-C                
mosquitoes homozygous for the transgene (n=32) were positive for ZIKV infection in their             
midguts, and while ZIKV infection was detected in 81.25% (26/32) of the TZIKV-C mosquitoes              
that were heterozygous for the transgene, these had significantly (p<0.001) lower viral RNA             
levels (~2 logs) than WT (Figure 2E, Table 1). TZIKV-C mosquito carcasses and dissected              
midguts at 14 dpi showed that none of the homozygous TZIKV-C mosquitoes (n=70) were              
positive for viral replication in either the midgut or the carcass by real-time RT-qPCR, while               
70% (49/70) of heterozygous mosquitoes had ZIKV in both the carcass and midgut, albeit with               
significantly (p<0.001) lower levels of viral RNA (~3 logs) than WT (Figure 2F-G, Table 1).               
Finally, ZIKV titre measurements on saliva from individual mosquitoes at 14 dpi demonstrated             
that no ZIKV was present in homozygous TZIKV-C mosquitoes (n=70), indicating that they             
would be unable to transmit the virus. Prevalence of ZIKV in saliva was detected in 70%                
(49/70) of TZIKV-C heterozygous mosquitoes; however, here again the ZIKV titres were            
significantly (p<0.001) lower (~3 logs) as compared with WT (Figure 2H, Table 1). 
 
Engineered mosquitoes outperform ​Wolbachia  
We next compared the inhibitory effect of our synthetic miRNAs to ZIKV inhibition             
previously shown with ​Wolbachia ​12,39–41​. Vector competence results revealed that midguts from            
mosquitoes (Higgs strain) infected with ​Wolbachia ( ​w​Mel strain; n=50) had significantly           
(p<0.001) reduced ZIKV (Puerto Rican strain) viral titres (~2 logs) at 4 dpi compared with WT                
(n=32; Figure 2E, Table 1). Similarly, viral dissemination at 14 dpi was also reduced (p<0.001)               
in ​w​Mel mosquitoes (~3 logs, n=50; Figure 2F-G, Table 1), and ZIKV titres in mosquito saliva at                 
14 dpi were significantly (p<0.01) lower (~2 logs) in ​w​Mel mosquitoes than in WT (Figure 2H,                
Table 1). Importantly, comparison to the TZIKV-C mosquitoes revealed that the TZIKV-C            
mosquitoes are significantly (p<0.001) more effective as homozygotes, and modestly more           
effective as heterozygotes (p<0.05), at blocking ZIKV infection compared with          
Wolbachia​-infected mosquitoes. 
 
Anti-ZIKV transgene inhibits ZIKV transmission in a mouse model  
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 To further characterize ZIKV inhibition by the anti-ZIKV transgene, we also conducted            
limited tests of ​in vivo transmission capacity on heterozygous TZIKV-C mosquitoes.           
Specifically, we utilized a very sensitive STAT knockout ( ​Stat1 ​-/-) mouse model, in which             
challenge with ZIKV (either intraperitoneally or via feeding by infected mosquito) rapidly causes             
systemic infections presenting high virema, resulting in significant weight loss, brain infections,            
and mortality ​42​. Firstly, we infected adult female mosquitoes (WT and TZIKV-C) with Puerto              
Rican ZIKV strain (PRVABC59) via thoracic injection, which bypasses the midgut barrier            
resulting in a significant viral titre in mosquitoes ​42​. At 7 dpi, TZIKV-C (n=28) and WT (n=29)                 
mosquitoes were separately pooled into four groups (with 6-12 individuals per group; Figure 3A)              
and each group was allowed to blood feed on a ​Stat1​-/- mouse, after which mouse weight and                 
survival were measured daily. All mice fed on by infected WT mosquitoes (n=4) became viremic               
and died prior to 8 dpi with significant weight loss prior to death (p<0.05; Figure 3B, C).                 
Conversely, out of the four mice fed on by TZIKV-C mosquitoes, only one showed mortality               
(albeit at a later date - 12 dpi), and no significant weight loss was observed compared to the                  
control group (p<0.0001; Figure 3B, C). Measurement of ZIKV titres in the individual             
mosquitoes utilized for this assay demonstrated that nearly all TZIKV-C mosquitoes ​had            
significantly reduced viral titers (~2 log) at 7 dpi compared to WT (p<0.0001; Figure 3A).  
To better simulate how mosquitoes naturally obtain pathogens (i.e., from blood feeding),            
we also performed the above assay with mosquitoes that were infected with ZIKV (strain              
PRVABC59) via oral membrane blood feeding, and obtained similar results. Specifically, at 14             
dpi via oral membrane blood feeding, TZIKV-C (n=16) and WT (n=20) mosquitoes were pooled              
into groups of 6-10 and allowed to feed on, and transmit the virus to, ​Stat1​-/- mice (n=2 for each                   
transgenic and WT; Figure 3D). The mice fed on by infected WT mosquitoes experienced              
significant weight loss and mortality prior to 8 dpi (p<0.0001; Figure 3E, F). Conversely, mice               
fed on by TZIKV-C mosquitoes showed no significant change in weight and no             
infection-associated mortality (p<0.0001, Figure 3E, F). Viral titre assays on these mosquitoes            
(at 14 dpi) indicated that ZIKV infection rate was dramatically reduced in TZIKV-C mosquitoes              
(39% of mosquitoes infected compared to 93% of WT; Figure 3D), and that viral titres of the                 
TZIKV-C mosquitoes that were infected were significantly lower (~2 log) than that of WT              
(p<0.0001, Figure 3D). Altogether, these results demonstrate that the anti-ZIKV transgene           
confers robust refractoriness to ZIKV infection and transmission, and that even mosquitoes            
heterozygous for the transgene are unlikely to be able to transmit the virus.   
 
Impact of anti-ZIKV transgene on mosquito fitness  
Finally, to determine whether the anti-ZIKV transgene had any significant fitness effects            
on transgenic mosquitoes, we assessed several fitness parameters including larval to pupal            
development time, male female fecundity and fertility, male mating success, adult wing length,             
and longevity (Table 2). No significant differences between WT and TZIKV-C mosquitoes were             
observed when examining male mating success, fecundity, and fertility (all ​p ​values > 0.9);              
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 female fecundity ( ​p ​>0.05); and male and female wing length ( ​p ​>0.05). Conversely, we observed             
a significant difference ( ​p ​<0.01) in hatching rates of eggs laid by WT versus TZIKV-C females               
(with the latter having lower hatching rates), and a significant difference between larval to pupal               
development time ( ​p ​<0.01), with TZIKV-C individuals developing faster. When assessing adult           
mosquito survivorship, no significant differences were observed between WT and TZIKV-C           
males ( ​p> ​0.05; Table 2, Supplementary Figure 4), while WT females survived slightly longer             
than TZIKV-C females ( ​p< ​0.0001; Table 2, Supplementary Figure 4). Furthermore, there was no             
significant difference in survival at 14 dpi between WT and TZIKV-C mosquitoes infected with              
the Cambodia ZIKV strain ( ​p ​>0.05; Table 2, Supplementary Table 2), and similarly no             
significant difference in survival between WT, ​w​Mel infected, and TZIKV-C mosquitoes           
infected with the Puerto Rico ZIKV strain ( ​p ​>0.05; Table 2, Supplementary Table 2). Based on               
the above observations, it does not appear that the anti-ZIKV transgene imposes any obvious              
major fitness costs to its carriers. 
 
Discussion 
Taken together, our results demonstrate that targeting conserved genes in the ZIKV            
genome by expressing an engineered polycistronic cluster of synthetic microRNAs confers           
homozygous mosquitoes complete refractoriness to multiple strains of ZIKV infection,          
dissemination, and transmission. Although incomplete, heterozygous mosquitoes also display         
partial refractoriness to ZIKV infection, dissemination, and transmission, with significant          
reduction of viral titres in the saliva (>2 logs compared to WT). This significant reduction of                
ZIKV is greater than the viral inhibition effect of ​Wolbachia​, and may be enough to ensure these                 
heterozygous mosquitoes are unable to transmit ZIKV to a susceptible host in the wild. Indeed,               
this latter point is supported by our finding that heterozygotes were largely unable to transmit               
ZIKV to immunocompromised ( ​Stat1 -/- ​) mice after infection via thoracic injection, and            
completely unable to transmit ZIKV after infection via membrane feeding. As intrathoracic            
injection generates unnaturally high infection levels by bypassing the mosquito midgut and            
lumen barriers ​42​, it is perhaps unsurprising that one mouse (possibly fed on by the single                
transgenic mosquito with unusual WT-like viral titre; Figure 3A) experienced ZIKV-associated           
mortality. However, the observation that most of the heterozygous anti-ZIKV mosquitoes           
infected via thoracic injection - and all of the mosquitoes infected via membrane feeding - were                
unable to transmit ZIKV to a susceptible mouse model, strongly suggests that even heterozygotes              
are unlikely to be capable of ZIKV transmission in the wild. 
Previously in ​Ae. aegypti ​, resistance to DENV has been engineered by transgenic            
activation of antiviral pathways ​25​, transgene-based RNAi in either the midgut ​26,43 or salivary              
glands ​27​, and antiviral hammerhead enzymes ​44​, and expression of synthetic miRNAs has also              
been demonstrated to induce partial resistance to DENV-3 and CHIKV ​31​. However, similar            
approaches have not been successfully demonstrated for ZIKV; and, the currently described            
system is potentially especially advantageous, since targeting 6/10 conserved protein-coding          
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 genes from the ZIKV genome with 8 separate synthetic miRNAs may reduce the possibility of               
escapee mutants and thus ensure evolutionary stability. That said, it remains uncertain how many              
synthetic miRNAs are necessary to ensure evolutionary stability in a wild population. Moreover,             
in our small RNA sequencing efforts we only detected expression/processing from 5 out of the 8                
synthetic miRNAs indicating that perhaps the RISC machinery is overloaded, or perhaps the             
CPA promoter is not strong enough to ensure robust expression from all 8 synthetic miRNAs, or                
possibly some synthetic miRNAs are unstable and get quickly degraded after processing. The             
latter hypothesis is supported by the fact that robust expression was only detected from synthetic               
miRNAs 1,2,4,6,8, while 3,5,7 were undetected and given that these are arranged numerically in              
a linear array (i.e. 1-8) miRNAs 3,5,7 must have been expressed/processed in order for 4,6,8 to                
be expressed/processed/detected. Therefore, future efforts should be focused on addressing these           
above open questions.  
Altogether, this strategy may provide a suitable “cargo” gene for practical use with a              
gene drive system to reduce/eliminate vector competence of mosquito populations. For example,            
previous reports have shown that Cas9-mediated homing based gene drive can be used for              
population modification of the malaria vector mosquito, ​Anopheles stephensi ​21​, and it should be              
possible to develop similar systems in ​Ae. aegypti ​. Given that homing based drive systems              
quickly convert heterozygotes into homozygotes ​4​, linking the anti-ZIKV transgene such as the             
one described here to such a system could quickly convert an entire mosquito population into               
anti-ZIKV homozygotes that would be 100% resistant to ZIKV transmission.  
Recent ZIKV outbreaks have shown that vector control remains an essential part of             
reducing the health burden of emerging arboviruses. Although the aim of this study was to               
illustrate feasibility of producing ZIKV-refractory mosquitoes, similar genetic engineering         
strategies could be used to develop (or improve on ​31​) single transgenes that render mosquitoes               
completely resistant to multiple arboviruses like DENV and CHIKV. Given the increasing            
incidence of these viral infections worldwide, such transgenes (coupled with gene drive systems)             
can provide an effective, sustainable, and comprehensive strategy for reducing the impact of             
arboviral mosquito-borne diseases. 
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 Figure 1​. Schematic of anti-ZIKV transgene, ZIKV target sites and phenotype of transgenic             
mosquitoes. A schematic of the anti-ZIKV transgene used in the study consisting of a              
carboxypeptidase A (AAEL010782) promoter (CPA) driving expression of a polycistronic          
cluster of eight synthetic miRNAs engineered to target conserved genes in the ZIKV genome.              
Following processing using the Drosha/exportin-5/Dicer pathway and loading into the          
RNA-induced silencing complex (RISC), the miRNAs and their target ZIKV viral RNA interact             
in the cytoplasm ( ​A ​). A schematic of the ZIKV genome consisting of three structural proteins               
(Capsid, prM, E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and              
NS5) with relative synthetic miRNA targets indicated by hairpin above ( ​B​). ​WT and TZIKV-C              
larvae ( ​C ​) and adult mosquitoes ( ​D ​) imaged under both transmitted light and a fluorescent              
dsRED filter. 
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Figure 2​. ZIKV titres in WT, TZIKV-C and ​Wolbachia infected mosquitoes challenged with             
either a Cambodian or a Puerto Rican ZIKV strain. ZIKV virus titres in wildtype (WT),               
anti-ZIKV homozygous (Hm) and heterozygous (Ht) transgenic mosquitoes, and         
Wolbachia-infected WT (Higgs- ​w ​Mel) following a blood meal infected with a Cambodian           
(FSS13025, ​A ​- ​D ​) or Puerto Rican (PRVABC59, ​E​- ​H​) strain of ZIKV are shown. Virus titres              
(TCID ​50​/ml equivalent) from mosquito midgut (day 4 ( ​A ​, E​) and day 14 ( ​B​, F​) post infection,                
dpi) and carcass (14 dpi ( ​C ​, G​)) of WT and transgenic mosquitoes were determined using               
real-time RT-qPCR and calculated using previously published methods. Virus titres in the saliva             
collected from WT and transgenic mosquitoes 14 dpi were determined using TCID ​50 on Vero              
cells and plotted ( ​D ​, H​). Circles represent WT mosquitoes; diamonds represent anti-ZIKV Hm             
transgenic mosquitoes; triangles represent TZIKV-C Ht mosquitoes; upside down triangles          
represent Higgs- ​w ​Mel mosquitoes. Horizontal bars represent the mean virus titre. *represents           
p<0.05 and **represents p<0.001. For each experiment, data from three replicates are pooled.  
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Figure 3​. Effect of anti-ZIKV transgene on ZIKV transmission in a mouse model. Wildtype              
(WT) and heterozygous TZIKV-C mosquitoes were infected with ZIKV strain PRVABC59           
thoracically ( ​A-C ​) or orally ( ​D-F ​), and assayed for their ability to transmit ZIKV to              
immunocompromised ​Stat -/- mice. Viral titres in carcasses of mosquitoes infected thoracically            
(measured at 7 dpi, ​A ​) and orally (measured at 14 dpi, ​D ​) were determined by plaque assay in                  
Vero cells and plotted. Mean body weight ( ​B, E​) and survival ( ​C ​, ​F​) of ​Stat -/- mice following                  
ZIKV infection by thoracially ( ​B​, ​C ​) or orally ( ​E, F​) infected WT and TZIKV-C mosquitoes               
were measured and plotted. For all plots ​(A-F) ​, white shapes represent results from WT              
mosquitoes; red shapes represent TZIKV-C mosquitoes. For viral titre plots, horizontal bars            
represent the mean virus titre, and vertical bars represent SEM. For mean body weight plots,               
vertical bars represent SEM.  ***represents p<0.0001.  
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Mosquito 
Line 
Zygosity Viral 
Strain 
Infection 
(Midgut 4 
dpi) 
  
Dissemination 
  
Transmission 
(Saliva 14 dpi) 
  
Midgut 
(14 dpi) 
Carcass  
(14 dpi) 
WT N/A FSS13025 42/50 
(84%) 
52/65 
(80%) 
52/65 (80%) 48/65 (73.8%) 
TZIKV-C Heterozygote FSS13025 28/32 
(87.5%) 
29/39 
(74.4%) 
29/39 
(74.4%) 
29/39 (74.4%) 
TZIKV-C Homozygote FSS13025 0/32 (0%) 0/46 (0%) 0/46 (0%) 0/46 (0%) 
WT N/A PRVABC59 28/32 
(87.5%) 
53/70 
(75.7%) 
53/70 
(75.7%) 
53/70 (75.7%) 
TZIKV-C Heterozygote PRVABC59 26/32 
(81.25%) 
49/70 
(70%) 
49/70 (70%) 49/70 (70%) 
TZIKV-C Homozygote PRVABC59 0/32 (0%) 0/70 (0%) 0/70 (0%) 0/70 (0%) 
Higgs  ​w ​Mel N/A PRVABC59 42/50 
(84%) 
38/50 
(76%) 
38/50 (76%) 38/50 (76%) 
  
Table 1. ​Anti-ZIKV transgene effect on ZIKV infection, dissemination, and transmission rates.            
ZIKV infection rates were quantified in the midgut at 4 days post infection (dpi). Dissemination               
rates were quantified in both the midgut and carcass at 14 dpi. Transmission rates were               
calculated by measuring prevalence of ZIKV in the saliva at 14 dpi. For each experiment, data                
from three replicates is pooled.  
 
 
 
 
 
 
 
18 
.CC-BY-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/344697doi: bioRxiv preprint first posted online Jun. 12, 2018; 
  
 
 
 
 
 Mosquito Strain  
Fitness Parameter 
WT 
(N) 
TZIKV-C 
(N) P​-value  
Female fecundity​ ​†​§ 102.5 ± 3.8 (65; 6,648) 113.2 ± 4.4 (65; 7,117) 0.0708 
Egg hatchability​ ​‖§ 70.9 ± 2.7 (63; 4,684) 58.5 ± 2.8 (63; 4,130) 0.0019 
Male mating success ​ ​ο¶ 92 ± 0.05 (25) 92 ± 0.05 (25) >0.9999 
Male fecundity​ ​l§ 118.2 ± 11.8 (25; 2,846) 119.2 ± 12.7 (25; 3,089) 0.9580 
Egg hatchability​ ​Ⅲ§ 61 ± 5.8 (23; 1,562) 60.7 ± 4.8 (23; 1,771) 0.9709 
Larval to pupal 
development in days ​ ​§ 
10.35 ± 0.07  
(1,224) 
9.836 ± 0.10  
(904) 
0.002 
Female wing length ​ ​§ 3.65 ± 0.02 (56) 3.62 ± 0.08 (58) 0.1489 
Male wing length ​ ​§ 2.76 ± 0.01 (54) 2.79 ± 0.01 (55) 0.0600 
Female median survival 
in days ​†† 
64 (124) 52 (124) <0.0001 
Male median survival in 
days ​†† 
18 (130) 
 
20 (120) 
 
0.2195 
% Survival at 14 dpi 
with ZIKV ​ ​‡††  
80.6 ± 3.5 (129) 75 ± 4.6 (88) 0.3636 
 ​Mean​±SEM reported. 
†​Average number of eggs laid per female. (Number of females scored; total number of eggs counted). 
‖​Percentage of laid eggs that produced larvae. (Number of females scored; total number of larvae counted). 
ο​Percentage of single male outcrosses that gave rise to viable progeny. 
l​Average number of eggs laid per single male outcross. (Number of male outcrosses scored; total number of eggs 
counted). 
Ⅲ​Percentage of laid eggs that produced larvae per single male outcross. (Number of male outcrosses scored; total 
number of larvae counted). 
§​Unpaired t test with Welch’s correction was used. 
¶ ​Unpaired t test was used to evaluate the statistical significance between the proportions of fertile males.  
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 ††​Mantel-Cox test was used.  
‡​Percentage of infected mosquitoes surviving at 14 dpi. Data from infection experiments with two different ZIKV                
strains (FSS13025 and PRVABC59) is pooled. 
 
Table 2. ​Fitness evaluation of WT and TZIKV-C mosquitoes. Comparisons of several fitness             
parameters (leftmost column) between WT (second column from left) and TZIKV-C mosquitoes            
(third column from left) suggest that there are few significant differences (rightmost column)             
between the two groups, indicating that the ani-ZIKV transgene does not have a major impact on                
mosquito fitness. 
 
Methods 
Synthetic anti-ZIKV miRNAs design and construction 
The ​Drosophila melanogaster ​miR6.1 stem-loop, which has been previously validated in ​D.            
melanogaster ​23​, was modified to target eight unique sites in the ZIKV polyprotein region as               
previously described ​24​. The eight target sites corresponded to regions of capsid (C), membrane              
precursor (prM), and envelope (E) structural genes, RNA-directed RNA polymerase NS5 (which            
contained three target sites), and non-structural proteins NS1 and NS2A, of ZIKV strain             
H/PF/2013 ( ​GenBank: KJ776791.2 ​) ​33​. These sites were highly conserved in ZIKV strain            
FSS13025 (Cambodia 2010, Genbank KU955593) ​37 and in ZIKV strain PRVABC59 (isolated           
from US traveller to Puerto Rico in 2015, GenBank KU501215) (Supplementary Figure 1). To              
generate miR6.1 stem-loop backbones that create mature synthetic miRNAs complementary to           
each of these target sites, pairs of primers were annealed and products were utilized for two                
subsequent rounds of PCR and cloned into the pFusA backbone (from the Golden Gate TALEN               
and TAL Effector Kit 2.0, Addgene #1000000024) in sets of four using Golden Gate assembly ​45                
to generate plasmids OA959A and OA959B. Assembled miRNAs were then digested with either             
PmeI/BglII (vector OA959A) or with BamHI/PacI (vector OA959B) and were subcloned into a             
PacI/PmeI-digested final vector OA959C (the anti-ZIKV transgene). The ZIKV target sequences           
and sequences of primers used in the miRNA cloning are listed in Supplementary Table 3. 
 
Plasmid Assembly 
To generate vector OA959C (the anti-ZIKV transgene), several components were cloned into the             
piggyBac plasmid ​pBac[3xP3-DsRed] ​46 using Gibson assembly/EA cloning ​47​. First, a           
Drosophila ​codon optimized tdTomato marker was amplified with primers 959C.10A and           
959C.10B fro ​m a ​gene synthesized vector (GenScript, Piscataway, NJ) ​and cloned into a             
XhoI/FseI digested pBac[3xP3-DsRed] backbone using EA cloning. The resulting plasmid was           
digested with AscI, and the following components were cloned in via EA cloning: the predicted               
Aedes aegypti carboxypeptidase promoter ​32 amplified from ​Ae. aegypti genomic DNA using            
primers 959C.11A and 959C.11B, a GFP sequence amplified from vector pMos[3xP3-eGFP] ​48            
with primers 959C.12A and 959C.12B, and a 677 bp p10 3’ untranslated region (UTR)              
amplified ​with primers 959C.13A and 959C.13B fr ​om vector        
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 pJFRC81-10XUAS-IVS-Syn21-GFP-p10 (Addgene plasmid #36432) ​. ​Assembled miRNA      
fourmers were then subcloned into final plasmid OA959C using PacI and PmeI using traditional              
cloning. All primer sequences are listed in Supplementary Table 4. Complete annotated plasmid             
sequence and DNA is available via Addgene (plasmid #104968). 
 
Generation of Transgenic Mosquitoes 
Germline transformations were carried out largely as described ​49​. Briefly, 0-1 hr old Higgs and               
Liverpool strain ​Ae. aegypti pre-blastoderm embryos were injected with a mixture of vector             
OA959C (200 ng/ul) and a source of ​piggyBac transposase (200 ng/ul) ​48​; the injected embryos               
were hatched in deoxygenated H ​2​O. A total of 52 surviving Higgs adult males and 64 surviving                
Higgs adult females, and 61 surviving adult Liverpool males and 75 surviving adult Liverpool              
females, respectively, were recovered after the injection. Higgs adults were assigned to 35 pools              
and Liverpool adults were assigned to 39 pools, and outcrossed to Higgs or Liverpool adults,               
respectively, of the opposite sex in cages. Larvae were fed ground fish food (TetraMin Tropical               
Flakes, Tetra Werke, Melle, Germany) and adults were fed with 0.3M aqueous sucrose. Adult              
females were blood fed three to five days after eclosion using anesthetized mice. All animals               
were handled in accordance with the guide for the care and use of laboratory animals as                
recommended by the National Institutes of Health and supervised by the local Institutional             
Animal Care and Use Committee (IACUC). A total of 8,189 Higgs and 10,949 Liverpool G ​1​s               
were screened. Larvae with positive fluorescent signals (3xp3-tdTomato) were selected under the            
fluorescent stereomicroscope (Leica M165FC) and were crossed to establish stable transgenic           
lines. Four independent lines (termed TZIKV-A, B, C, and D) with the strongest fluorescence              
expression patterns were selected for further characterization. To determine whether these lines            
represented single chromosomal insertions, we backcrossed single individuals from each of the            
lines for four generations to wild-type stock, and measured the Mendelian transmission ratios in              
each generation; in all cases, we observed a 50% transmission ratio, indicating insertion into              
single chromosomes. For one of the four lines (TZIKV-C), transgenic mosquitoes were inbred             
for at least 12 generations to generate a homozygous stock. Mosquito husbandry was performed              
under standard conditions as previously described ​50​.  
 
Characterization of Transgene Genomic Insertion Sites 
To characterize the insertion site of vector OA959C in transgenic mosquitoes, we adapted a              
previously described inverse polymerase chain reaction (iPCR) protocol ​51 as follows. Genomic            
DNA (gDNA) was extracted from 10 transgenic ​Ae. aegypti fourth instar larvae using the              
DNAeasy Blood & Tissue Kit (Qiagen #69504) per the manufacturer’s protocol. Two separate             
restriction digests were performed on diluted gDNA to characterize the 5’ and 3’ ends of the                
insertion using Sau3AI (5’ reaction) or HinP1I (3’ reaction) restriction enzymes. A ligation step              
using NEB T4 DNA Ligase (NEB #M0202S) was performed on the restriction digest products to               
circularize digested gDNA fragments, and two subsequent rounds of PCR were carried out per              
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 ligation using corresponding ​piggyBac primers listed in Supplementary Table 5. Final PCR            
products were cleaned up using the MinElute PCR Purification Kit (Qiagen #28004) in             
accordance with the manufacturer’s protocol, and sequenced via Sanger sequencing (Source           
BioScience, Nottingham, UK). To confirm transgene insertion locus and orientation via PCR,            
primers were designed based on iPCR mapped genomic regions and used in tandem with              
piggyBac primers based on their location as listed in Supplementary Table 5. Sequencing data              
was then blasted to the AaegL5.0 ​reference genome (NCBI). An alignment of the sequencing              
data was carried out with SeqManPro (DNASTAR, Madison, WI) to determine orientation of the              
transgene insertion site. Analysis of the sequencing data ​indicated that ​the insertion sites were on               
chromosome 2 (at approximate position 167,899,561) for line TZIKV-A, on chromosome 3 (at             
approximate position 402,525,313) for line TZIKV-B, on chromosome 3 (at approximate           
position 173,647,938) for line TZIKV-C, and on chromosome 1 (at approximate position            
228,972,549) for line TZIKV-D. These insertion locations were also confirmed by PCR and             
sequencing  performed on genomic DNA from the transgenic mosquitoes. 
 
Small RNA Extraction, Isolation, Sequencing, and Bioinformatics.  
Total RNA was extracted from midguts of 30 ZIKV-C transgenic and WT (Higgs strain)              
non-blood-fed adult females as well as midguts of 30 ZIKV-C transgenic and WT (Higgs strain)               
adult females 24 hours post blood-feeding using the Ambion mirVana mRNA Isolation Kit             
(ThermoFisher Scientific #AM1560). Following extraction, RNA was treated with Ambion          
Turbo DNase (ThermoFisher Scientific #AM2238). The quality of RNA was assessed using            
RNA 6000 Pico Kit for Bioanalyzer (Agilent Technologies #5067-1513) and a NanoDrop 1000             
UV–vis spectrophotometer (NanoDrop Technologies/Thermo Scientific, Wilmington, DE).       
Small RNA was then extracted and prepared for sequencing with QIAseq miRNA Library Kit              
(Qiagen #331502). Libraries were quantified with Qubit dsDNA HS Kit (ThermoFisher           
Scientific #Q32854) and High Sensitivity DNA Kit for Bioanalyzer (Agilent Technologies           
#5067- 4626) and sequenced on Illumina HiSeq2500 in single read mode with the read length of                
75 nt following manufacturer's instructions. After adapter trimming and UMI extraction, reads            
were aligned to mature ​Ae. aegypti miRNAs downloaded from miRBase (release 22, ​52​) and to               
each synthetic miRNA’s passenger, loop, and guide sequences using bowtie2 in           
‘very-sensitive-local’ mode. Custom Perl scripts were used to quantify the number of reads that              
mapped to each target. Correlation coefficients of TPM values between WT and transgenic             
animals were calculated in R​53​. Differential expression analysis was performed with R package             
DESeq2 using two factor design (design= ~ feeding + genotype). TPM values, MA, and volcano               
plots were generated with R package ggplot2 (Supplementary Figure 3). Quantification data are             
shown in Supplementary Table 1. ​All sequencing data can be accessed at NCBI SRA (accsession               
ID: SRP150144; BioProject ID: PRJNA475410). 
 
ZIKV Infection of Mosquitoes, Virus Determination and Longevity 
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 All experiments were performed under biosafety level 3 (BSL-3) conditions in the insectary at              
the Australian Animal Health Laboratory. Insectary conditions were maintained at 27.5℃ and            
70% in relative humidity with a 12hr light/dark cycle. ZIKV strain FSS13025 (Cambodia 2010,              
Genbank KU955593) ​37 or PRVABC59 (Puerto Rico 2015, GenBank KU501215) were used for            
viral challenge experiments. Both belong to the Asian/Pacific/American clade and were passaged            
once in C6/36 cells and twice in Vero cells before using for mosquito infections. WT (Higgs or                 
Liverpool strain) and transgenic (confirmed by red fluorescence in the eye) mosquitoes were             
infected with ZIKV as previously described ​54​. Briefly, female mosquitoes were challenged with             
a chicken blood meal spiked with ZIKV (TCID ​50 10​6​/mL) through chicken skin membrane             
feeding. Blood-fed female mosquitoes were sorted and maintained at standard conditions in an             
environmental cabinet with sugar ​ad libitum​. For infection rate and virus titer, mosquito midguts              
were collected at 4 dpi. For dissemination and transmission rate, mosquito saliva, midguts, and              
carcasses were collected at 14 dpi. Mosquito saliva was used to determine viral titers using               
TCID ​50 assay on Vero cells. Midguts and carcasses were used to determine presence of viral               
RNA using RT-qPCR against ZIKV NS5 ​54 ​(Supplementary Table 5) ​. Mosquito viral challenge,             
processing, saliva testing, and molecular analyses of infection and dissemination were carried out             
as previously described ​54​. ZIKV infection rate was defined by the number of midguts (4 dpi)                
found positive for viral nucleic acid over tested midguts. Similarly, the dissemination rate was              
calculated by the number of carcasses (14 dpi) testing ZIKV positive by qPCR. Transmission              
rate was defined by the number of TCID ​50 positive saliva samples over the number tested. For                
each experiment, data from three replicates was pooled. The average TCID ​50 values were             
compared by two-tailed unpaired t test. To measure fitness after infection, blood-fed            
ZIKV-infected females were quickly sorted out after CO ​² anaesthesia and housed in waxed             
cardboard cup 250 ml containers with a maximum of 25 mosquitoes. Mosquitoes were             
maintained at standard conditions for 14 days with 10% sugar solution ​ad libitum​. Dead              
mosquitoes were counted daily. Females surviving at day 14 were marked as censored (status=0)              
in the database for survival analysis, which was performed using the GraphPad Prism software              
( ​GraphPad Software, La Jolla California, USA ​). The Mantel-Cox test was used to compare the              
survival of infected mosquitoes at 14 dpi. 
 
Generation of ​w ​Mel ​Wolbachia ​ Line and Infection Assay 
Eggs of ​Ae. aegypti infected with the ​Wolbachia strain ​w​Mel were obtained from the World               
Mosquito Program (Prof. Scott O’Neill, Monash University). Higgs mosquitoes infected with           
w​Mel were generated by crossing ​w​Mel+ females with males from the Higgs line, and the               
resulting offsprings were used for ZIKV infections experiments. At the end of the experiment,              
Wolbachia infection status of these mosquitoes was tested using PCR with primers specific for              
w​Mel detection ​55 ​(Supplementary Table 5). The PCRs indicated presence of ​w​Mel in >90% of               
mosquitoes, and only results from these positive mosquitoes were used for further analysis. 
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 Mouse Transmission Assays 
All experiments were performed under biosafety level 3 (BSL-3) conditions in the insectary at              
NHRI. Insectary conditions were maintained at 29°C and 80% relative humidity with a 12 hr               
light/dark cycle, and mosquitoes were maintained as previously described ​42​. For experimental            
assays, transgenic anti-ZIKV mosquitoes were outcrossed to WT (Higgs strain) for a generation             
to obtain heterozygotes. ZIKV strain PRVABC59 (Puerto Rico 2015, GenBank KU501215) was            
used for viral challenge experiments. It was obtained from the Taiwan Center for Disease              
Control, and maintained/amplified as previously described ​42​. For direct ZIKV infection, 7–10            
day-old female mosquitoes were inoculated with 200 plaque forming units (pfu) of ZIKV by              
thoracic injection as previously described ​42 and maintained under standard housing conditions            
for 7 days prior to their use in assays. Infection via artificial membrane blood feeding was                
carried out as ​described above, and infected mosquitoes were then maintained under standard             
conditions for 14 days prior to their use in transmission assays. Viral titers were measured at 7                 
dpi (for thoracic injection infections) or 14 dpi (for membrane blood feeding infection) by plaque               
assay as previously described ​42,56​. ​Briefly, 2x10​5 cells/well of Vero cells (a kind gift from Dr.                
Guann-Yi Yu) were incubated for one day (in serum-free 1xDMEM medium (HyClone,            
SH30022), at 37℃) before being infected with ZIKV. At two hours post infection, unbound              
virus particles were removed, and cells were gently washed by PBS and overlaid with 3 ml of                 
1xDMEM medium containing 2% FBS (Gibco, 16000044), 10 mM HEPES, 10nM sodium            
pyruvate, 2mM L-Glutamine (Gibco, 25030081), 1x Penicillin-Streptomycin (Gibco, 15140122),         
and 1% Methyl cellulose (Sigma, M0512-250G). The infected cells were then incubated at 37℃              
and 5% CO ​2 for 4 days until plaque formation. Cells were fixed and stained with 0.5mL crystal                 
violet/methanol mixed solution (ASK®Gram Stain Reagent) for 2 hours, and washed with H ​2​O.             
Number of plaques was then calculated, and viral titers were determined as plaque forming units               
per mosquito and were compared by​ ​one-way ANOVA. 
All mouse-related experiments were conducted in compliance with the guidelines of the            
Laboratory Animal Center of NHRI. The animal protocol (NHRI-IACUC-105111) was approved           
by the Institutional Animal Care and Use Committee of NHRI, according to the Guide for the                
Care and Use of Laboratory Animals (NRC 2011). Management of animal experiments and             
animal care and use practices of NHRI have been accredited by the AAALAC International.              
Stat1​-/- (C57BL/6 background) mice were provided by Dr. Guann-Yi Yu (NTU, Taiwan). Both             
male and female mice between the ages of 11-12 weeks were used in the study. 
Mosquito-mediated ZIKV mouse infections were carried out as previously described ​42,56​.           
Briefly, mice were anesthetized with Ketalar (100 mg/Kg, Pfizer, New York, NY) via             
intraperitoneal injection, and their ventral surfaces were shaved. Then, mice were placed on top              
of a polyester mesh covering a mosquito-housing cage that permitted female mosquitoes to take              
a blood meal. Female mosquitoes were starved for 10h before they were allowed to take blood                
meals from mice, and each mouse was fed on by 6–11 mosquitoes. Mouse body weight and                
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 mortality were then recorded for 6-30 days. Mouse weights were compared by the Mann              
Whitney test to evaluate for significant weight loss. 
 
Fitness Assessment and Conditions 
To determine if the anti-ZIKV transgene confers a fitness cost, several fitness parameters were              
evaluated in WT and transgenic mosquitoes. Evaluation of all experimental and control            
replicates were performed simultaneously. Insectary conditions were maintained at 28℃ and           
70-80% in relative humidity with a 12hr light/dark cycle. To assess larval to pupal development               
time, eggs were vacuum hatched and larvae were distributed into pans (50 larvae per pan)               
containing 2.5L of ddH ​2​O and 0.6mL of fish food slurry. To determine the development time of                
transgenic and WT control mosquitoes, 4th instar larvae were sorted according to fluorescence             
phenotype and reared until pupation. Pupae were collected and counted every day until no pupae               
were left. To assess female fertility and fecundity, 90 females were mated to 20 WT males in a                  
cage. After four days, females were blood fed and individually transferred into plastic vials filled               
with water and lined with egg paper. After three days, egg papers were collected, and eggs were                 
counted and vacuum hatched in 9-ounce plastic cups. Starting on the fourth day, larvae were               
counted every day until no larvae were present. Female fecundity refers to the number of eggs                
laid per female, and fertility reflects the number of eggs hatching to produce larvae. To measure                
male mating success, fecundity, and fertility, one transgenic or control male was mated to five               
WT females in a single cup filled with water and lined with egg paper. Three days post blood                  
meal, cups were checked for the presence of eggs, which were collected, counted, and hatched.               
Hatched larvae were then counted every day until no larvae were present. Male mating success               
was calculated as the percentage of single male outcrosses that produced larvae. Fecundity was              
measured as the number of eggs laid per cup; fertility was determined by the number of hatching                 
larvae in each cup. To asses wing length as a proxy for body size, images of mosquito wings                  
were taken with a Leica M165 FC microscope (Leica Microsystems). Wing length measurements             
were done by using the measurement tool on the Leica Application Suite X, measuring from the                
axial incision to the intersection of the R 4+5 margin. Finally, to assess mosquito longevity,               
equal numbers of male and female experimental or WT mosquitoes were placed in medium sized               
cages (in triplicate). Mosquitoes that died were counted and removed daily until all mosquitoes              
had died. Statistical analyses were performed using the GraphPad Prism software ( ​GraphPad            
Software, La Jolla California, USA ​). Means were compared using unpaired t tests with Welch’s              
correction except for male mating success (no Welch’s correction). Analyses of mosquito            
survivorship utilized the Mantel-Cox test. ​P​-values>0.05 were considered non-significant.  
 
Confirmation of Transgene Zygosity 
To molecularly confirm zygosity of transgenic mosquitoes, mosquito heads were homogenised           
using bead-beater for DNA extraction in 30 ul extraction buffer (1x Tris-EDTA, 0.1M EDTA,              
1M NaCl and 2.5 uM proteinase K), and incubated at 56°C for 5 minutes and then at 98°C for 5                    
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 minutes. PCR was then performed on each line to detect the presence of the transgene by pairing                 
a ​piggyBac primer with a genomic primer as follows: primers 1018.S46 and 991.5R2 for              
TZIK-A, 1018.S26 and 991.3F2 for TZIK-B, 1018.S8 and 991.5R1 for TZIK-C, and 1018.S50             
and 991.3F2 for TZIK-D (Supplementary Table 5). To determine zygosity, we amplified the WT              
locus of each transgenic line using corresponding forward and reverse primers listed in             
Supplementary Table 5. A PCR kit (ThermoFisher Scientific #F553S) with 57°C annealing            
temperature and standard protocols was used for all PCRs. 
 
Data Availability Statement 
All sequencing data associated with this study are available from NCBI sequence read archive              
(SRA) ​accession ID: SRP150144; BioProject ID: PRJNA475410 ​. Complete annotated plasmid          
sequence and DNA is publically available at Addgene (plasmid #104968). Transgenic           
mosquitoes will be made available by corresponding author upon request.  
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Supplemental Figures and Tables 
 
 
Supplementary Figure S1. ​miRNA target site conservation between ZIKV strains H/PF/2013,           
FSS13025, and PRVABC59. miRNA target sites between the ZIKV strain used for miRNA             
target selection (H/PF/2013, top sequence) and the strains used for mosquito challenges            
(FSS13025, middle sequence; PRVABC59, bottom sequence) are highly conserved, with only           
one base pair mismatch in one target site in each strain (shown in red). 
 
 
Supplementary Figure S2: ​Effect of anti-ZIKV transgene on ZIKV titres in four independent             
mosquito lines. ZIKV virus titres in wildtype (Liverpool WT and Higgs WT), anti-ZIKV             
transgenic mosquito lines (TZIKV-A, TZIKV-B, TZIKV-C, TZIKV-D) following a blood meal           
infected with a Cambodian (FSS13025) are shown. Virus titres (TCID50/ml equivalent) from            
mosquito midgut (day 4 post infection) of WT and transgenic mosquitoes were determined using              
real-time RT-qPCR and calculated using previously published methods. Circles represent WT           
mosquitoes; black diamonds represent anti-ZIKV Hm transgenic mosquitoes; red colored          
diamonds represent anti-ZIKV Ht transgenic mosquitoes. Horizontal bars represent the mean           
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 virus titer. Mantel-Cox test was used for statistical analysis. **represents p<0.001. 
 
 
 
Supplementary Figure S3. Differential expression analysis of miRNAs from WT and TZIKV-C            
mosquito midguts. TPM (transcripts per million) values for transgenic versus WT animals            
without a blood meal ( ​A ​) and 24 hours after a blood meal ( ​B​) are shown. Expression of synthetic                  
miRNAs does not affect expression levels of endogenous miRNAs significantly (correlation           
coefficients of 0.9761 and 0.9757, respectively). MA (log2FoldChange vs. baseMean)(​C ​) and           
‘volcano’ (-log10 (p-value) vs. log2FoldChange))(​D ​) plots demonstrate that only synthetic          
miRNAs are differentially expressed between WT and transgenic animals.  
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Supplementary Figure S4. Survivorship curve of WT and TZIKV-C male and female            
mosquitoes. The x-axis indicates the number of elapsed days after the start of the experiment,               
and the y-axis indicates the percent of mosquitoes surviving on each elapsed day. Each line               
represents accumulated results from 120-130 adult mosquitoes combined from 3 biological           
replicates.  
 
Supplementary Table S1. Quantification of endogenous and engineered miRNA expression on           
read and UMI (Unique Molecular Identifiers) levels in WT and TZIKV-C mosquitoes prior to              
blood meal (NBF) and 24 hr post blood feeding (PBM). Both raw read or UMI counts and                 
normalized TPM (Transcripts Per Million) values are shown.  
 
Supplementary Table S2. The survivorship of ZIKV-infected TZIKV-C mosquitoes at 14 days            
post infection (dpi). WT, ​w​Mel+, and TZIKV-C mosquitoes infected with ZIKV strain            
FSS13025 or PRVABC59 were assessed for survival at 14 dpi. The mean percentage±SEM of              
surviving mosquitoes and number of mosquitoes tested (in parentheses) are reported. No assay             
was performed for ​w​Mel mosquitoes infected with strain FSS13025. The Mantel-Cox test was             
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 used to compare the survival of infected WT, ​w​Mel (for PRVABC59 strain only), and              
anti-ZIKV mosquitoes.  
 Mosquito strains  
Virus strain WT  
WT 
w​Mel 
TZIKV-
C P-value 
FSS13025 
(Cambodia) 
64.1% ± 6.6 (53) -- 73.6% ± 6.1 (53) 0.2528 
PRVABC59  
(Puerto Rico) 
92.1% ± 3.0 (76) 86.9% ± 5.0 (46) 77.1% ± 7.0 (35) 0.0817 
 
 
Supplementary Table S3. ​Primer sequences and miRNA target sites utilized to generate            
synthetic miRNA constructs used in this study. Self annealing primers are listed first, and consist               
of forward and reverse target site sequences flanking the stem loop region of the synthetic               
miRNA. Primers amplifying flanking regions, BsaI cut sites, and multiple cloning site are listed              
below.  
 
Primer  Primer Sequence, 5’ to 3’ Source 
miRNA 1 
959C.1A 
  
  
959C1.B 
  
ATCACAGCCTTTAATGTACACAAAGCACTTGATTAGCGTTAAGTTAATAT
ACCATATCTA 
  
TTAGGCACTTTAGGTACACACAAAGCACTTGATTAGAGTTAGATATGGT
ATATTAACTTA 
Self annealing 
primers 
miRNA 2 
959C.2A 
  
  
959C.2B 
  
  
ATCACAGCCTTTAATGTGGAATGCCCACTCAAACATCGATAAGTTAATA
TACCATATCTA 
  
TTAGGCACTTTAGGTACGGAATGCCCACTCAAACATAGATAGATATGGT
ATATTAACTTA 
Self annealing 
primers 
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 miRNA 3 
959C.3A 
  
  
959C.3B 
  
  
ATCACAGCCTTTAATGTGGATTGTCAATATGCTAAACCGTAAGTTAATAT
ACCATATCTA 
  
TTAGGCACTTTAGGTACGGATTGTCAATATGCTAAAACGTAAGTTAATAT
ACCATATCTA 
Self annealing 
primers 
miRNA 4 
959C.4A 
  
  
959C.4B 
  
  
ATCACAGCCTTTAATGTATAGAGCGAAGGTTGAGATCACTAAGTTAATA
TACCATATCTA 
  
TTAGGCACTTTAGGTACATAGAGCGAAGGTTGAGATAACTAGATATGGT
ATATTAACTTA 
Self annealing 
primers 
miRNA 5 
959C.5A 
  
  
959C.5B 
  
  
ATCACAGCCTTTAATGTGGAGAATGAAGCTCTAATCCCCTAAGTTAATAT
ACCATATCTA 
  
TTAGGCACTTTAGGTACGGAGAATGAAGCTCTAATCACCTAGATATGGT
ATATTAACTTA 
Self annealing 
primers 
miRNA 6 
959C.6A 
  
  
959C.6B 
  
  
ATCACAGCCTTTAATGTCGAATGGCAGTCAGTGGAGCTGTAAGTTAATA
TACCATATCTA 
  
TTAGGCACTTTAGGTACCGAATGGCAGTCAGTGGAGATGTAGATATGGT
ATATTAACTTA 
Self annealing 
primers 
miRNA 7 
959C.7A 
  
  
959C.7B 
  
  
ATCACAGCCTTTAATGTAGAAGTGAAAGGATACACATAATAAGTTAATA
TACCATATCTA 
  
TTAGGCACTTTAGGTACAGAAGTGAAAGGATACACAAAATAGATATGGT
ATATTAACTTA 
Self annealing 
primers 
miRNA 8 
959C.8A 
  
  
959C.8B 
  
  
ATCACAGCCTTTAATGTTGACCACAAAGATCATCATCAGTAAGTTAATAT
ACCATATCTA 
  
TTAGGCACTTTAGGTACTGACCACAAAGATCATCATAAGTAGATATGGT
ATATTAACTTA 
Self annealing 
primers 
720C 
  
  
720D 
TTTAAAGTCCACAACTCATCAAGGAAAATGAAAGTCAAAGTTGGCAGCT
TACTTAAACTTAATCACAGCCTTTAATGT 
  
AAAACGGCATGGTTATTCGTGTGCCAAAAAAAAAAAAAATTAAATAATG
ATGTTAGGCACTTTAGGTAC 
Self-annealed 
products of 
959C.#A/959C
.#B 
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 miRNAs 
1,5 
959C.C1 
  
 
720F.1 
  
  
 
TCTAGAGGTCTCGCTATCGGCGGCCGCGCGTTTAAACAACCGGATCCTTT
AAAGTCCACAACTCATC 
 
CTCGAGGGTCTCCCATGGTCAAAACGGCATGGTTATTCGTG 
Self-annealed 
products of 
720C/720D-1 
and 
720C/720D-5 
miRNAs 
2,6 
720E-2 
  
720-F2 
  
 
TCTAGAGGTCTCCCATGGCTTTAAAGTCCACAACTCATCAAGGA 
  
CTCGAGGGTCTCGGTCCTGAAAACGGCATGGTTATTCGTGTGC 
Self-annealed 
products of 
720C/720D-2 
and 
720C/720D-6 
miRNA 3,7 
720-E3 
  
720-F3 
  
 
TCTAGAGGTCTCAGGACCATTTAAAGTCCACAACTCATCAAGGAA 
  
CTCGAGGGTCTCCCTGGCAAAAACGGCATGGTTATTCGTGTGC 
Self-annealed 
products of 
720C/720D-3 
and 
720C/720D-7 
miRNA 4,8 
720-E4 
  
959C.C2 
  
  
 
TCTAGAGGTCTCGCCAGGATTTAAAGTCCACAACTCATCAAGGA 
  
CTCGAGGGTCTCCCGCCACTGCGGCCGCTTAATTAATGGCCGGCCAAAG
ATCTAAAACGGCATGGTTATTCG 
Self-annealed 
products of 
720C/720D-4 
and 
720C/720D-8 
miRNA 
target site 1 
 
ACACAAAGCACTTGATTAGAGT 
Membrane 
glycoprotein 
precursor M 
miRNA 
target site 2 
 
GGAATGCCCACTCAAACATAGA 
Nonstructural 
protein NS1 
miRNA 
target site 3 
 
GGATTGTCAATATGCTAAAACG 
Capsid protein 
C 
miRNA 
target site 4 
 
ATAGAGCGAAGGTTGAGATAAC 
Envelope 
protein E 
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 miRNA 
target site 5 
 
GGAGAATGAAGCTCTAATCACC 
RNA-depende
nt RNA 
polymerase 
NS5 
miRNA 
target site 6 
 
CGAATGGCAGTCAGTGGAGATG 
RNA-depende
nt RNA 
polymerase 
NS5 
miRNA 
target site 7 
 
AGAAGTGAAAGGATACACAAAA 
RNA-depende
nt RNA 
polymerase 
NS5 
miRNA 
target site 8 
 
TGACCACAAAGATCATCATAAG 
Nonstructural 
protein NS2A 
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Supplementary Table S4. ​Primers used to assemble plasmid OA959C (the anti-ZIKV 
transgene).  
 
Fragment and 
Primers 
Primer Sequence, 5’ to 3’ Source 
tdTomato marker  
959C.10A 
959C.10B 
 
GACGGTACGATCCACCGGTCGCCACCATGGTGAGCAAGGGCGAGGA
GGTCATCAAAGAGT 
TGGTATGGCTGATTATGATCTAGAGTCGCGGCCGCCTACTTGTACAG
CTCGTCCATGCCG 
Gene 
synthesized 
vector 
Carboxypeptidase 
promoter 959C.11A 
959C.11B 
  
ATGGTTAATTCGAGCTCGCCCGGGGTCCTAGGGAATTCGTCAATAA
AAAAATACGTTCAA 
CTCCTCGCCCTTGCTCACCATGTTTAAACTTTCCCAACTAACCGATA
CACACTAACCTG 
Genomic ​Ae. 
aegypti 
DNA 
GFP marker 
959C.12A 
959C.12B 
  
 
AGTGTGTATCGGTTAGTTGGGAAAGTTTAAACATGGTGAGCAAGGG
CGAGGAGCTGTTCAC 
TGATTTGTTATTTTAAAAACGATTCATTCTAGTTAATTAATTACTTGT
ACAGCTCGTCCATGCC 
pMos[3xP3-
eGFP] 
p10 3’ UTR 
959C.13A 
959C.13B 
  
 
GGACGAGCTGTACAAGTAATTAATTAACTAGAATGAATCGTTTTTA
AAATAACAAAT 
TCCCCGGGCGAGCTCGAATTGGCGCGCCCGGCCGTTAACTCGAATC
GCTATCCAAGC 
pJFRC81-10
XUAS-IVS-
Syn21-GFP-
p10 
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 Supplementary Table S5. ​ Diagnostic primers used for inverse PCR (iPCR) assays, zygosity 
confirmation, ZIKV NS5 RT-qPCR, and ​w​Mel infection confirmation. 
piggyBac ​ Primers 
Reaction Primer Name Primer Sequence, 5’ to 3’ 
5’ (1st Round PCR) 991.5F1 
GACGCATGATTATCTTTTACGTGAC 
991.5R1 
TGACACTTACCGCATTGACA 
5’(2nd Round PCR) 991.5F2 
GCGATGACGAGCTTGTTGGTG 
991.5R2 
TCCAAGCGGCGACTGAGATG 
3’ (1st Round PCR) 
991.3F1 
CAACATGACTGTTTTTAAAGTACAAA 
991.3R1 
GTCAGAAACAACTTTGGCACATATC 
3’ (2nd Round 
PCR) 991.3F2 
CCTCGATATACAGACCGATAAAAC 
991.3R2 
TGCATTTGCCTTTCGCCTTAT 
Zygosity Primers 
Reaction Line Primer 
Name 
Primer Sequence, 5’ to 3’ 
Forward primer TZIK-A 1018.S46 GTACTGGCACCCATAGCTCG 
TZIK-B 1018.S27 GCAAATCCTAAAACCTCATCGAACCG 
TZIK-C 1018.S8 TTTCCACGAAATGAACTCAAACGC 
 
TZIK-D 1018.S48 ACGTTATGCAAATCTCTCGGAT 
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 Reverse primer 
TZIK-A 1018.S47.1 CGAAAATTGCGTTTACCTTATACGT 
TZIK-B 1018.S26 AATCGAATGAACGAATTTCTGATTAAATCC 
TZIK-C 1018.S10 AGAAGAACAGAGGCAATCAACTACATTGA 
 
TZIK-D 1018.S50 CCATCTTTCGATGGAAATGCATT 
ZIKV NS5 RT-qPCR Primers 
Primer​ ​name Primer Sequence, 5’ to 3’ 
NS5-F 
 
GAACGAGGATCACTGGATGG 
NS5-R 
 
CTCCTGGTATGCGACTCATC 
w​Mel Primers 
Primer​ ​name Primer Sequence, 5’ to 3’ 
w​Mel-F 
CAAATTGCTCTTGTCCTGTGG 
w​Mel-R 
GGGTGTTAAGCAGAGTTACGG 
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